Article Text
Abstract
We present a diagnostically challenging case of a 61-year-old man presenting with progressive weakness and intermittent low-grade fever.
- Neurobrucellosis
- BRUCELLOSIS
Statistics from Altmetric.com
The case
A 61-year-old Libyan man was admitted under a medical team with a 3-month history of lethargy and mild generalised weakness. He reported minimal right ear hearing loss and impaired balance. His family reported mild irritability during this period.
He had recently started a statin for hypercholesterolaemia but had no other significant medical history. He was a self-employed businessman who had moved to the UK 15 years earlier.
On initial examination, cognition was normal. Cranial nerve examination identified minimal right hearing loss. He had a broad-based gait and could not perform tandem gait. Romberg's test was negative. He had minimal (Medical Research Council scale for muscle power (MRC) 5-/5) weakness in the small muscles of his right hand and a very mild asymmetric pyramidal weakness in his legs, with the right leg slightly weaker. Reflexes were preserved throughout with the exception of absent ankle jerks. Sensation remained intact in all four limbs. Neurological examination was otherwise normal.
Initial investigations
He had a mild normocytic anaemia, normal liver function tests, urea and electrolytes, vitamin B12 and folate and negative antinuclear antibody, anti-neutrophil cytoplasmic antibody and Venereal Disease Research Laboratory (VDRL). Inflammatory markers including erythrocyte sedimentation rate and C reactive protein were both normal. MR scan of brain without contrast was normal. MR scan of the whole spine without contrast showed minor cervical spondylosis without cord compression or signal change.
He was discharged with a request for an outpatient neurological opinion.
Four weeks following discharge, he was readmitted with deteriorating mobility and increased weakness. He had more significant weakness in the small muscles of his right hand with mildly reduced upper limb reflexes. He had a waddling gait. Both quadriceps muscles had become wasted and there were fasciculations in the right quadriceps. Leg tone was flaccid. Power had decreased dramatically in both legs, in a pyramidal distribution. Leg reflexes were absent with initially flexor plantar responses, though these responses later became unresponsive. Sensation remained unaffected.
Further investigations
Repeat MR scan of whole spine was normal. Nerve conduction studies were normal. Needle electromyography showed chronic partial denervation changes in both lower limbs (right more than left) with positive sharp waves and fasciculation potentials. There were similar but less severe changes in both arms. The findings suggested a subacute proximal neurogenic process, most likely affecting the anterior horn cells or motor roots. Table 1 gives his cerebrospinal fluid (CSF) results.
We gave him empirical intravenous ceftriaxone and aciclovir. More detailed systemic enquiry identified a several month history of low-grade headaches and intermittent chills. These first appeared following a trip to Libya. While an inpatient he had an intermittent low-grade fever but blood cultures were repeatedly negative. HIV testing was negative. There was no history of contact with either tuberculosis or polio.
Table 2 gives the result of his second lumbar puncture 1 week later.
His weakness increased and he lost anti-gravity power in his leg muscles, other than knee extension and ankle plantar flexion. Leg reflexes became absent. Plantar responses were mute.
CSF India ink and acid-fast bacilli staining, herpes simplex virus/varicella zoster virus/cytomegalovirus/Epstein-Barr virus/enterovirus PCR, cryptococcal antigen and tuberculosis PCR were all negative. A Heaf test was strongly positive (grade IV necrotic reaction). We started him on empirical anti-tuberculosis quadruple therapy (rifampicin, isoniazid, pyrazinamide and ethambutol) with prednisolone 80 mg daily (tapered slowly over 6 weeks) and pyridoxine. His weakness plateaued but did not improve.
Given the CSF cytology findings, we looked for an occult malignancy. Tumour markers, whole body CT-positron emission tomography and bone marrow examination were normal, as was repeat CSF cytology.
Further microbiological and virological tests including Borrelia and Brucella serology (complement fixation test) and micro-agglutination assay were performed at the National Reference Laboratory. Human T-lymphotropic virus and schistosomiasis serology, enterovirus PCR (stool sample), atypical pneumonia screen (Q fever, chlamydia and mycoplasma) and anti-neuronal antibodies, all returned negative. Prolonged CSF tuberculosis and fungal cultures were both negative. CSF ACE was elevated at 2.84 U/L (normal <1.2). MR scan of whole spine with contrast showed diffuse enhancement of some nerve roots within the cauda equina of uncertain significance but was considered at the time to be related to multiple lumbar punctures.
Further lumbar punctures showed a rising CSF white cell count (peaking at 217 monocytes), an absence of atypical cells and unmatched CSF oligoclonal bands. CSF West Nile virus PCR was negative. CSF immunotyping found no monoclonal expansion of lymphocytes.
Given the ongoing suspicion of neurological infection, a further opinion was sought from HM. During this consultation, the patient was further questioned about his trips to Libya. He had always stayed in Tripoli but had drunk unpasteurised milk purchased from a small dairy shop, of the type commonly found in Libya. The onset of his presenting symptoms were closely related to his most recent trip to Libya. As such, despite the recent negative serological testing, HM strongly suspected neurobrucellosis, which remains endemic in Libya. Further blood and CSF samples were sent to the National Reference Laboratory for retesting. Both CSF and serum ELISA returned strongly positive for Brucella IgG, providing serological confirmation of neurobrucellosis. Subsequently, the patient's original blood sample was reanalysed and found to be strongly positive. An investigation disclosed that there had been a simple administrative error, resulting in an incorrect result being released for the initial sample (table 3).
Following receipt of these results, we started him on oral doxycycline 100 mg twice daily and continued the rifampicin 300 mg twice daily. We stopped all his other anti-tuberculous treatment. Within 1 week his headache and intermittent low-grade fever resolved and his leg muscle strength improved (table 4).
With additional prolonged neurorehabilitation, he went on to make an excellent recovery without residual weakness. Six months after adding doxycycline, he had mild sensory ataxia, normal limb muscle bulk and power, bilateral extensor plantar responses and minor proprioceptive loss in both big toes. Hearing and cognition were normal. His serum vitamin B12 level was at the lower limit of normal and so he was loaded with intramuscular vitamin B12. Spinal MRI remained normal. Repeat electromyography showed mild-to-moderate chronic partial denervation with re-innervation in leg muscles. He completed a total of 6 months of combined doxycycline and rifampicin, preceded by 3 months of anti-tuberculous quadruple therapy, including rifampicin (table 5).
Discussion
Brucellosis is a zoonotic disease most commonly caused by ingestion of undercooked meat or unpasteurised milk from infected animals such as sheep, goats or cattle. Camel's milk is a particular risk factor as it is not usually pasteurised and herds are rarely vaccinated. Camel milk consumption is especially common in Somalia and among the UK's Somali population. The prevalence of brucellosis has decreased with the introduction of eradication programmes in animal vectors but it remains endemic in the Mediterranean basin, Middle East, Africa and parts of South America. Neurobrucellosis is a rare but important complication of this condition since it carries significant morbidity yet remains treatable. Estimates of the prevalence of neurological manifestations in patients with brucellosis vary widely but typically range between 3% and 6%.1
The clinical presentation of neurobrucellosis is heterogeneous. Severe and persistent headache with fever are the most commonly reported symptoms, affecting 70%–85% of cases. Neuropsychiatric symptoms, peripheral neuropathy, confusion and ataxia may also occur. Cranial nerve palsies occur in 19% of patients,2 with sensorineural hearing loss being the most common finding in several retrospective analyses.2–4
Broadly speaking, neurobrucellosis presents either acutely or, as here, more chronically.8 The acute form presents as meningoencephalitis with headache, vomiting and reduced consciousness. Classically, this responds well to early antibiotic treatment. The chronic form may present with (1) proximal polyradiculopathy developing over the course of several months, causing progressive flaccid paraparesis, with denervation on electromyography, (2) myelitis or (3) myeloradiculopathy.5 In the latter form, the leg muscles are more severely affected, often in a pyramidal distribution. There may be additional cranial nerve involvement. Meningovascular complications (including subarachnoid, intracerebral and subdural haemorrhages and venous sinus thrombosis) can occur with neurobrucellosis. Our patient had myeloradiculopathy and his presentation was dominated by polyradiculopathy, with the myelitic component (extensor plantar responses) becoming evident only after recovery of power (box 1).
Summary of systemic and neurological features of neurobrucellosis
Summary of clinical features of neurobrucellosis
Systemic features
Fever
Myalgia
Weight loss
Fatigue
Arthralgia
Vomiting
Low back pain
Neurological features
Headache
Confusion
Neuropsychiatric symptoms
Cranial nerve palsies (especially sensorineural hearing loss)
Peripheral neuropathies
Polyradiculopathy
Myelitis
Myeloradiculopathy
Meningovascular complications
As with all fastidious bacteria, culture of Brucella from CSF is uncommon and diagnosis of neurobrucellosis therefore requires serological testing of both blood and CSF samples. However, there is no agreement on the diagnostic antibody titre, with levels of ≥80 previously having been accepted as diagnostic when accompanied by symptoms that suggest neurobrucellosis. In the UK, the Health Protection Authority reported that three patients, including this patient, were confirmed as having neurobrucellosis with positive CSF Brucella antibody testing between 2001 and 2008.5 All three patients came from, or had recently visited, an area endemic for brucellosis and, in all three of these patients, the corresponding serum Brucella antibody test was also positive (although, in our case, we were initially misinformed that the first serum Brucella serology had tested negative). No patient with negative blood serology had positive CSF samples. There is a real-time PCR developed to detect Brucella, which is highly sensitive and specific and could become an important tool to diagnose neurobrucellosis.
Due to limited therapeutic data there are very few guidelines on the optimal management of neurobrucellosis. The general consensus is that antibiotic regimens should include doxycycline (bactericidal) and rifampicin (bacteriostatic) and a 2012 study suggested that regimens containing ceftriaxone lead to shorter courses of antibiotic therapy.6 Brucella species are intracellular organisms and this therefore confers protection, at least in part, against many antibiotics. As such, their eradication requires a prolonged course of treatment. The ideal duration of treatment remains unclear, but 2–4 months is suggested depending on the severity; CSF monitoring is a useful adjunct to assess response to therapy.7 Prolonged courses of antibiotics are also associated with a lower chance of relapse. Adjunctive corticosteroids can reduce inflammation in neurobrucellosis but there are few studies on this.
In conclusion, we have presented a case of neurobrucellosis where the diagnosis proved challenging. Although extremely rare, it is an important differential diagnosis to consider, given that it is treatable and can mimic other conditions, particularly tuberculosis. Clinicians who suspect neurobrucellosis should obtain a comprehensive travel history and request serum Brucella serology, to avoid unnecessary CSF Brucella antibody testing. If neurobrucellosis remains likely, then matched serum and CSF samples should be sent for Brucella antibody testing. We recommend empirical treatment with a regimen including doxycycline and rifampicin, while awaiting the results of serological testing.
Key points
Neurobrucellosis can mimic poliomyelitis, West Nile virus infection, tuberculous myeloradiculopathy and malignant meningitis.
In cases of suspected brucellosis, take blood and possibly cerebrospinal fluid for Brucella serology.
Suspected cases require a thorough travel history, since this can be more valuable than serological testing.
Patients with suspected neurobrucellosis should receive doxycycline and rifampicin empirically, while awaiting serological results.
Footnotes
Contributors JM authored the manuscript with contributions from DS. HM reviewed the manuscript and suggested changes. AE oversaw the paper and made corrections and changes throughout.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by Nicholas Davies, London, UK.